Neuren Pharmaceuticals | NEU - Current Liabilities

Stock Price
12.73
Daily Change
0.49 4.00%
Monthly
-26.63%
Yearly
-2.38%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD7.92M in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 133.38M 14.66M Sep/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.6M 42.44M Jun/2025
Clinuvel Pharmaceuticals AUD 25.21M 4.17M Jun/2024
Dianthus Therapeutics USD 23.86M 3.76M Sep/2025
Genetic Signatures AUD 4.1M 348K Jun/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
Medical Developments International AUD 7.82M 1.45M Jun/2025
Neuren Pharmaceuticals AUD 7.92M 37.84M Jun/2025
Organon & Co USD 2.68B 117M Sep/2025
Paradigm Biopharmaceuticals AUD 3.23M 2.15M Jun/2025
PYC Therapeutics AUD 12.32M 939.58K Jun/2025
Starpharma Holdings AUD 5.23M 378K Jun/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Telix Pharmaceuticals AUD 231.62M 66.96M Dec/2025
Viatris USD 7.36B 230.7M Sep/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025